9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Vinorelbine in Mesothelioma

Vinorelbine in Mesothelioma

Estimated reading time: < 1 min

Condition: Mesothelioma

Estimated Enrollment: 157

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Active, not recruiting

Study Results: No Results Available

Outcome Measures: Overall Survival,  Progression Free Survival,  Number of serious adverse events reported, BRCA1 status in blood and tumour samples

Interventions: Vinorelbine, Active Symptom Control

Phase:

Study Type: Interventional

Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: None (Open Label),Primary Purpose: Treatment

Primary Completion Date: October 31, 2019

Completion Date: January 1, 2020

Last  Posted Date: May 1, 2019

Location: Wales Cancer Trials Unit, Cardiff, United Kingdom

Website Link: https://ClinicalTrials.gov/show/NCT02139904

Was this article helpful?
Dislike 0